SAN

76.41

0%↓

UCB

249.2

-1.66%↓

SHL.DE

38.83

-0.23%↓

ARGX

612

-0.42%↓

PHIA

24.4

-0.49%↓

SAN

76.41

0%↓

UCB

249.2

-1.66%↓

SHL.DE

38.83

-0.23%↓

ARGX

612

-0.42%↓

PHIA

24.4

-0.49%↓

SAN

76.41

0%↓

UCB

249.2

-1.66%↓

SHL.DE

38.83

-0.23%↓

ARGX

612

-0.42%↓

PHIA

24.4

-0.49%↓

SAN

76.41

0%↓

UCB

249.2

-1.66%↓

SHL.DE

38.83

-0.23%↓

ARGX

612

-0.42%↓

PHIA

24.4

-0.49%↓

SAN

76.41

0%↓

UCB

249.2

-1.66%↓

SHL.DE

38.83

-0.23%↓

ARGX

612

-0.42%↓

PHIA

24.4

-0.49%↓

Strona główna・Stock List・Vetoquinol SA

Vetoquinol SA

Closed

SectorHealthcare

77.3 -1.02

Buy Sell

Overview

Share price change

24h

Current

Min

77.1

Max

77.8

Key metrics
By Trading Economics
Income	25M
Sales	258M
P/E Sector Avg	15.902 61.417
Dividend yield	1.12
Profit margin	9.734
Employees	2,497
EBITDA	48M

Dividends
By Dow Jones
Dividend yield Sector Avg	1.12% 2.40%
Next Earnings	27 mar 2026

Market Stats
By TradingEconomics
Market Cap	960M
Previous open	78.32
Previous close	77.3

News Sentiment

By Acuity

50%

154 / 351 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

72.6 / 75.1 Support & Resistance

Vetoquinol SA Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

13 mar 2026, 19:08 UTC

Major News Events

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

13 mar 2026, 18:48 UTC

Earnings

Major Market Movers

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

13 mar 2026, 17:10 UTC

Major News Events

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

13 mar 2026, 17:10 UTC

Major News Events

Week Ahead for FX, Bonds: Central Bank Decisions -2-

13 mar 2026, 16:47 UTC

Major News Events

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

13 mar 2026, 22:27 UTC

Market Talk

Major News Events

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

13 mar 2026, 22:13 UTC

Market Talk

Major News Events

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

13 mar 2026, 22:04 UTC

Market Talk

Major News Events

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

13 mar 2026, 22:00 UTC

Acquisitions, Mergers, Takeovers

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

13 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar 2026, 20:50 UTC

Market Talk

Major News Events

Financial Services Roundup: Market Talk

13 mar 2026, 20:02 UTC

Market Talk

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

13 mar 2026, 19:50 UTC

Market Talk

Major News Events

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

13 mar 2026, 19:35 UTC

Major News Events

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

13 mar 2026, 19:00 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower -- Market Talk

13 mar 2026, 18:49 UTC

Major News Events

The Iran War Could Upend AI. Here's How. -- Barrons.com

13 mar 2026, 18:24 UTC

Major News Events

Impact of Middle East Conflict on TotalEnergies Activities

13 mar 2026, 18:00 UTC

Major News Events

Is War Good For the Economy? -- WSJ

13 mar 2026, 17:23 UTC

Market Talk

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

13 mar 2026, 16:46 UTC

Market Talk

Major News Events

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

13 mar 2026, 16:38 UTC

Major News Events

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

13 mar 2026, 16:34 UTC

Acquisitions, Mergers, Takeovers

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

13 mar 2026, 16:33 UTC

Acquisitions, Mergers, Takeovers

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

13 mar 2026, 16:32 UTC

Acquisitions, Mergers, Takeovers

EQT Completes Exit From Galderma

13 mar 2026, 16:20 UTC

Market Talk

Major News Events

Financial Services Roundup: Market Talk

13 mar 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

13 mar 2026, 16:15 UTC

Major News Events

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

13 mar 2026, 16:11 UTC

Market Talk

Carney Tries to Put Dismal Canada Jobs Data in Context -- Market Talk

13 mar 2026, 16:00 UTC

Major News Events

Here's Where the U.S. Economy Is Most Vulnerable to Iran War -- WSJ

13 mar 2026, 15:48 UTC

Market Talk

Major News Events

Oil Futures Turn Higher as Supply Worries Remain -- Market Talk

Peer Comparison

Price change

Vetoquinol SA Forecast

Rating Consensus

By TipRanks

0 ratings

Buy

Hold

Sell

Based on 0 analysts giving stock ratings to Vetoquinol SA - Dist in the past 3 months.

Technical Score

By Trading Central

72.6 / 75.1Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

Sentiment

By Acuity

154 / 351 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Vetoquinol SA

Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, dogs, cats, and horses. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.